Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
Yosipovitch, G
Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients. [electronic resource] - Archives of dermatology Apr 2001 - 477-81 p. digital
Publication Type: Comparative Study; Journal Article; Review
0003-987X
Adult
Age Factors
Aged
Calcitonin--therapeutic use
Calcium--therapeutic use
Controlled Clinical Trials as Topic
Densitometry
Diphosphonates--therapeutic use
Estrogen Replacement Therapy
Estrogens, Conjugated (USP)--administration & dosage
Exercise
Female
Fractures, Bone--prevention & control
Glucocorticoids--administration & dosage
Humans
Male
Meta-Analysis as Topic
Middle Aged
Osteoporosis--chemically induced
Osteoporosis, Postmenopausal--prevention & control
Raloxifene Hydrochloride--therapeutic use
Risk Factors
Selective Estrogen Receptor Modulators--therapeutic use
Skin Diseases--drug therapy
Time Factors
Vitamin D--therapeutic use
Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients. [electronic resource] - Archives of dermatology Apr 2001 - 477-81 p. digital
Publication Type: Comparative Study; Journal Article; Review
0003-987X
Adult
Age Factors
Aged
Calcitonin--therapeutic use
Calcium--therapeutic use
Controlled Clinical Trials as Topic
Densitometry
Diphosphonates--therapeutic use
Estrogen Replacement Therapy
Estrogens, Conjugated (USP)--administration & dosage
Exercise
Female
Fractures, Bone--prevention & control
Glucocorticoids--administration & dosage
Humans
Male
Meta-Analysis as Topic
Middle Aged
Osteoporosis--chemically induced
Osteoporosis, Postmenopausal--prevention & control
Raloxifene Hydrochloride--therapeutic use
Risk Factors
Selective Estrogen Receptor Modulators--therapeutic use
Skin Diseases--drug therapy
Time Factors
Vitamin D--therapeutic use